Most Active Stocks
Follow the most active stocks today, including share price changes, trading volume, and more. We cover the most traded stocks with daily market data, news, and analysis from our Foolish experts, helping you make informed investing decisions.
Related Articles
Featured Article
Meet the Monster Stock That Continues to Crush the Market
Rick Orford
|
Aug 19, 2025
Discover why this company's silence could be the most bullish signal yet -- and the hidden catalyst that could ignite the next big rally.

Think Advanced Micro Devices Stock Is Expensive? These 2 Charts Might Change Your Mind.
Will Healy
|
Aug 19, 2025
AMD stock appears poised for significant gains.

Huge News for Palantir Stock Investors
Parkev Tatevosian, CFA
|
Aug 19, 2025
The company is experiencing soaring demand for its services.

Meet the Monster Stock That Continues to Crush the Market
Geoffrey Seiler
|
Aug 19, 2025
Palantir has been the best-performing stock in the S&P over the past two years.

5 Monster Stocks to Hold for the Next 5 Years
Geoffrey Seiler
|
Aug 19, 2025
Growth stocks look poised to continue to lead the market higher.

This Pure-Play Artificial Intelligence (AI) Stock Is Up 140% This Year but Trades at an Unsustainable Level, According to Famed Short-Seller Andrew Left
Bram Berkowitz
|
Aug 19, 2025
Many large artificial intelligence stocks trade at meteoric valuations.

4 Fintech Growth Stocks to Buy With $260 and Hold Forever
Justin Pope
|
Aug 19, 2025
A modest investment in these industry disruptors could turn into big money over the long haul.

Predicting the Next Rule Breaker Buyout
Motley Fool Staff
|
Aug 19, 2025
Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table?

Should You Buy Nvidia Stock Before Aug. 27? Here's What History Suggests.
Adam Spatacco
|
Aug 18, 2025
Nvidia stock is scheduled to report second-quarter earnings on Aug. 27.

Why Viking Therapeutics Stock Zoomed 5% Higher Today
Eric Volkman
|
Aug 18, 2025
The company is a front-runner in the race to develop an orally administered weight loss drug.

View More Articles